BRJ Medical
The global demand for insulin syringes with needles has reached an all-time high, driven by the increasing prevalence of diabetes mellitus worldwide. According to the International Diabetes Federation (IDF), approximately 537 million adults are currently living with diabetes, a number projected to rise to 783 million by 2045. This epidemiological shift has transformed the insulin delivery device industry into a critical sector of the global healthcare economy.
Leading insulin syringe factories are now focusing on the intersection of patient comfort and clinical precision. The industrial status of this sector is characterized by a move towards ultra-fine needle gauges (31G, 32G) and advanced lubrication technologies to minimize injection pain. Regionally, while North America and Europe remain high-value markets due to advanced healthcare infrastructure, the Asia-